Inhibitory effect of Ssanghwa-tang on bone loss in ovariectomized rats

Animal Cells and Systems

Volumn 14, Issue 4, 2010, Pages 283-289

  Shim, Ki Shuk ^a   Lee, Ji Hye ^a   Ma, Choong Je ^b   Lee, Yoon Hee ^a   Choi, Sung Up ^a   Lee, Jaehoon ^a   Ma, Jin Yeul ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

Bone mineral density; Osteoclast differentiation; Ovariectomy; RAW264.7 cells; Ssanghwa tang

Indexed keywords

RATTUS;

EID: 79957654239     PISSN: 19768354     EISSN: 21512485     Source Type: Journal    
DOI: 10.1080/19768354.2010.528615     Document Type: Article

References (28)

1. Asagiri M, Takayanagi H. 2007. The molecular understanding of osteoclast differentiation. Bone. 40:251-264.
2. Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature. 423:337-342.
3. Branca F. 2003. Dietary phyto-oestrogens and bone health. Proc Nutr Soc. 62:877-887.
4. García Palacios V, Robinson LJ, Borysenko CW, Lehmann T, Kalla SE, Blair HC. 2005. Negative regulation of RANKL-induced osteoclastic differentiation in RAW 264.7 cells by estrogen and phytoestrogens. J Biol Chem. 280:13720-13727.
5. Han DS, Lee HK, Cho HJ. 1983. Analgesic and anticonvulsionary effects of Ssanghwa-Tang. Kor J Pharmacog. 14:60-63.
6. Han YH, Shim CK. 1989. Effect of a blended Korean herbal remedy, Ssang Wha Tang, on the liver cytoplasmic protein binding of sulfobromophthalein in rats. Phytother Res. 3:109-111.
7. Heo J. 1994. Dongeuibogam. Seoul: Namsandang Press. p. 670-675.
8. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, et al. 1999. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA. 96:3540-3545.
9. Kalu DN. 1991. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 15:175-191.
10. Kil JS, Kim MG, Choi HM, Lim JP, Boo Y, Kim EH, Kim JB, Kim HK, Leem KH. 2008. Inhibitory effects of Angelicae Gigantis Radix on osteoclast formation. Phytother Res. 22:472-476.
11. Kim IH, Hwang KJ. 1981. Studies on the anti-inflammtory activities of Ssangwha-tang. Natural Pro Sci. 12:131-136.
12. Lee H, Lim HH. 2003. Effects of Ssangwha-tang added to Cervi Cornu Parvum on bone density and bone biochemical marker in ovariectomized rats. J Ori R Med. 13:45-67.
13. Lelovas PP, Xanthos TT, Thoma SE, Lyritis GP, Dontas IA. 2008. The laboratory rat as an animal model for osteoporosis research. Comp Med. 58:424-430.
14. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCT method. Methods. 25:402-408.
15. Lowe C, Yoneda T, Boyce BF, Chen H, Mundy GR, Soriano P. 1993. Osteoporosis in Src-deficient mice is due to an autonomous defect of osteoclasts. Proc Natl Acad Sci USA. 90:4485-4489.
16. Oh KO, Kim SW, Kim JY, Ko SY, Kim HM, Baek JH, Ryoo HM, Kim JK. 2003. Effect of Rehmannia glutinosa Libosch extracts on bone metabolism. Clin Chim Acta. 334:185-195.
17. Okamoto F, Okabe K, Kajiya H. 2001. Genistein, a soybean isoflavone, inhibits inward rectifier K(-) channels in rat osteoclasts. Jpn J Physiol. 51:501-509.
18. Pang M, Martinez AF, Fernandez I, Balkan W, Troen BR. 2007. AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells. Gene. 15:151-158.
19. Putnam SE, Scutt AM, Bicknell K, Priestley CM, Williamson EM. 2007. Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health. Phytother Res. 21:99-112.
20. Qin L, Han T, Zhang Q, Cao D, Nian H, Rahman K, Zheng H. 2008. Antiosteoporotic chemical constituents from Er-Xian Decoction, a traditional Chinese herbal formula. J Ethnopharmacol. 118:271-279.
21. Rodan GA, Martin TJ. 2000. Therapeutic approaches to bone diseases. Science. 289:1508-1514.
22. Rozen S, Skaletsky HJ. 2000. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 132:365-386.
23. Saftig P, Hunziker E, Everts V, Jones S, Boyde A, Wehmeyer O, Suter A, von Figura K. 2000. Functions of cathepsin K in bone resorption. Lessons from cathepsin K deficient mice. Adv Exp Med Biol. 477:293-303.
24. Soriano P, Montgomery C, Geske R, Bradley A. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693-702.
25. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, et al. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 3:889-901.
26. Teitelbaum SL. 2000. Bone resorption by osteoclasts. Science. 289:1504-1508.
27. Won JB, Ma JY, Um YR, Ma CJ. 2010. Simultaneous determination of five marker constituents in Ssanghwa tang by HPLC/DAD. Pharmacogn Mag 6:111-115.
28. Yen PH, Kiem PV, Nhiem NX, Tung NH, Quang TH, Minh CV, Kim JW, Choi EM, Kim YH. 2007. A new monoterpene glycoside from the roots of Paeonia lactiflora increases the differentiation of osteoblastic MC3T3-E1 cells. Arch Pharm Res. 30:1179-1185.